PFIZER INC (PFE)
US7170811035 - Common Stock
Pfizer Just Reassured Investors, but Is the Stock a Buy?
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025
When things seem too good to be true on Wall Street, they usually are.
My Top 10 Stocks to Buy for 2025
Pfizer cost cutting leads to Tampa layoffs
Notable Friday Option Activity: RYTM, PFE, PEP
Neuropathic Pain Market Set to Witness Significant Growth by 2024-2031 | Pfizer, Inc., Johnson & Johnson Services
Global Neuropathic Pain Market is estimated to valued at US$ 7.56 Billion in 2023 and expected to exhibit a CAGR of 6.2% during the forecast period 2023-2030
Why Pfizer (PFE) Dipped More Than Broader Market Today
Pfizer (PFE) concluded the recent trading session at $25.77, signifying a -0.46% move from its prior day's close.
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
These S&P500 stocks are the most active in today's session
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
Pfizer Sparks Analyst Cheer With 2025 Guidance: Retail Maintains Extremely Bullish Stance
Some analysts are optimistic about Pfizer’s potential for growth, especially considering its focus on oncology and recent strategic acquisitions.
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
Under the deal's terms, Hansoh Pharma receives $112 million up front and a potential $1.9 billion in milestone payments.
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:PFE),(NYSE:GSK),(NYSE:BMY) EQNX::TICKER_END
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Here are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth investors, while value investors typically prefer to look elsewhere. You can scoop up a share of BioNTech for less than $120 at the time of this writing.
3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025
These top-tier income stocks are sporting an average yield of 8.53%!
Market Monitor December 17
Stocks fell on Tuesday, with the Dow Jones dropping 0.6%, marking its 9th straight decline—the longest streak since 1978—as investors await the Federal Reserve's interest rate decision.
S&P 500 Gains and Losses Today: Health Care Stocks Fall as Trump Eyes 'Middlemen'
The S&P 500 slid 0.4% on Tuesday, Sept. 17, as stocks faltered ahead of Wednesday's Federal Reserve's interest rate announcement.
Trump: Will 'Knock Out' Pharma Middlemen
Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump is “very committed” to reforming drug-industry middlemen. Bloomberg News' John Tozzi speaks with Sonali Basak on "Bloomberg Markets." (Source: Bloomberg)
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Tuesday Sector Leaders: Healthcare, Consumer Products
Looking for the most active stocks in the S&P500 index on Tuesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
What's going on in today's session: S&P500 most active stocks
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Which S&P500 stocks are moving on Tuesday?
Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more
These are the stocks posting the largest moves in midday trading.
Health Insurers Fall as Pfizer CEO Says Trump Wants PBM Reform
(Bloomberg) -- Shares of pharmacy benefit managers extended losses Tuesday after Pfizer Inc. Chief Executive Officer Albert Bourla said President-elect Donald Trump is “very committed” to reforming drug-industry middlemen. Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearBourla’s remarks, following comments from Trump Monday and continued criticism from members of Congress,
S&P 500 Movers: AMTM, ON
Pfizer Stock Rises as 2025 Outlook in Line With Expectations
Pfizer shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.
Pfizer Eyes 2025 Earnings Growth as CEO Touts 'Discipline'
Pfizer (PFE) projected higher earnings for 2025 and revenue in line with this year's likely result a
Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook
The company also reiterated its outlook for 2024.
Pfizer Stock Jumps After 2025 Revenue Outlook Offsets $1B Hit From Inflation Reduction Act Changes: Retail’s More Bullish
Pfizer said the projection reflects stable revenue from COVID-19 products, excluding approximately $1.2 billion of non-recurring revenue for Paxlovid in 2024.
Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more
These are the stocks posting the largest moves in premarket trading.
These S&P500 stocks are the most active in today's session
What's going on in today's session: S&P500 most active stocks
Which S&P500 stocks are the most active on Tuesday?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session.
Stay informed about the most active stocks in the S&P500 index on Tuesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Looking for the most active stocks in the S&P500 index on Tuesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.